✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Regeneron Pharmaceuticals Inc

Common Name
Regeneron Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
15,343
Ticker
REGN
Exchange
Nasdaq
Description
Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases across eye care, immunology, oncology, cardiovascular ...

Regeneron Pharmaceuticals's Board Composition Data

Explore Regeneron Pharmaceuticals's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026-02-04
Total Board Member Count
13a
Executive Board Member Count
2a
Non-executive Board Member Count
11a
Female Board Member Count
4a
Male Board Member Count
9a
Non-binary Board Member Count
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Regeneron Pharmaceuticals’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Regeneron Pharmaceuticals's Annual Report 2025